Othman Al-Sawaf

Clinical researcher in chronic lymphocytic leukemia who presented pooled-trial data on the impact of patient fitness and venetoclax-obinutuzumab dose intensity on treatment outcomes in CLL.

Best podcasts with Othman Al-Sawaf

Ranked by the Snipd community

Nov 13, 2025 • 19min

New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials

Join Dr. John Semple, a researcher at Lund University specializing in transfusion-related lung injuries, as he discusses how mitochondrial DNA acts as a critical trigger for TRALI via TLR9 signaling. Dr. Othman Al-Sawaf studies chronic lymphocytic leukemia and reveals surprising insights about patient fitness, highlighting that both fit and unfit patients respond similarly to treatment with venetoclax and obinutuzumab. Their research challenges existing views and suggests new pathways for understanding and treating these conditions.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app